Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Cilazapril

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,518Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 Alivus Life Sciences
    India
    		 ALIVUS LIFE SCIENCES LIMITED Mumbai IN CEP 2014-076 - Rev 02 Cilazapril, D169 2025-04-03 Valid Chemical 1499
    29/11/2025 Alivus Life Sciences
    India
    		 ALIVUS LIFE SCIENCES LIMITED Mumbai IN CEP 2006-200 - Rev 04 Cilazapril 2025-04-03 Valid Chemical 1499